Stockreport

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF – Multilayered Intellectual Property Strategy Provides Protection Into 2041 in the United States and Into 2039 Internationally, Unless Extended Further – NEW YORK Mar [Read more]